SBRT/LDRT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SBRT/LDRT, covering 2022-05-02 to 2022-05-02. Get the full timeline:
Most recent: Clinical Trial Update: SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy [Phase 2]